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Abstract
Background: Unrepaired DNA double-stranded breaks (DSBs) cause chromosomal rearrangements, loss of genetic
information, neoplastic transformation or cell death. The nonhomologous end joining (NHEJ) pathway, catalyzing
sequence-independent direct rejoining of DSBs, is a crucial mechanism for repairing both stochastically occurring
and developmentally programmed DSBs. In lymphocytes, NHEJ is critical for both development and genome
stability. NHEJ defects lead to severe combined immunodeficiency (SCID) and lymphoid cancer predisposition in
both mice and humans. While NHEJ has been thoroughly investigated in lymphocytes, the importance of NHEJ in
other cell types, especially with regard to tumor suppression, is less well documented. We previously reported
evidence that the NHEJ pathway functions to suppress a range of nonlymphoid tumor types, including various
classes of sarcomas, by unknown mechanisms.
Results: Here we investigate roles for the NHEJ factor ARTEMIS in multipotent mesenchymal stem/progenitor cells
(MSCs), as putative sarcomagenic cells of origin. We demonstrate a key role for ARTEMIS in sarcoma suppression in
a sensitized mouse tumor model. In this context, we found that ARTEMIS deficiency led to chromosomal damage
but, paradoxically, enhanced resistance and proliferative potential in primary MSCs subjected to various stresses.
Gene expression analysis revealed abnormally regulated stress response, cell proliferation, and signal transduction
pathways in ARTEMIS-defective MSCs. Finally, we identified candidate regulatory genes that may, in part, mediate a
stress-resistant, hyperproliferative phenotype in preneoplastic ARTEMIS-deficient MSCs.
Conclusions: Our discoveries suggest that Art prevents genome damage and restrains proliferation in MSCs
exposed to various stress stimuli. We propose that deficiency leads to a preneoplastic state in primary MSCs and is
associated with aberrant proliferative control and cellular stress resistance. Thus, our data reveal surprising new
roles for ARTEMIS and the NHEJ pathway in normal MSC function and fitness relevant to tumor suppression in
mesenchymal tissues.
Background
Nonhomologous end joining (NHEJ) is a critical DNA
double-stranded break repair pathway, important in the
repair of general DNA double-stranded breaks and pro-
grammed DSBs generated during B- and T-lymphocyte
development [1,2]. Cells lacking NHEJ exhibit variable
proliferative defects, hypersensitivity to ionizing radia-
tion and other clastogens and spontaneous chromoso-
mal instability. Numerous studies have implicated NHEJ
as a key suppressor of lymphoid tumorigenesis, both in
humans and in experimental models [3-5]. The tumor-
suppressive role of NHEJ is thought to be largely via
prevention of oncogenic chromosomal rearrangements
relating to failed lymphocyte development. More
recently, we and others have shown that NHEJ is a
tumor-suppressive pathway in multiple nonlymphoid tis-
sues, though the detailed mechanisms remain essentially
unknown [6-8].
ARTEMIS (encoded by the Art/Dclre1c gene) is a DNA
processing exo/endonuclease that acts together with
the DNA-dependent protein kinase (DNA-PK) to prepare
DNA ends for ligation by the core NHEJ machinery
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[9,10]. Accumulating evidence has also pointed to DNA
damage response or checkpoint activation roles for Art
that may be distinct from its DNA repair activities
[11-15]. Thus, Art may uniquely function as a key inte-
grator of DNA damage signals, cellular response and
DNA repair. In this context, Art is important in both
general DNA double-stranded break (DSB) repair and in
specialized repair of programmed DNA breaks during V
(D)J recombination in developing B- and T-lymphocytes
[3,9,10]. Mutations in Art underlie human radiosensitive
severe combined immunodeficiency (RS-SCID) and
SCID-A, primary immunodeficiencies associated with
hypersensitivity to DNA-damaging agents and variable
lymphoma predisposition [5,9,10,16-18].
We recently demonstrated a role for Art in suppression
of several classes of sarcomas, including osteosarcomas,
chondrosarcomas, rhabdomyosarcomas and poorly differ-
entiated anaplastic sarcomas. In this context, we postulate
a role for Art in suppressing neoplastic transformation of
mesenchymal stem/progenitor cells (MSCs), closely
related multipotent mesenchymal stromal cells (MMS), or
their descendants. MSCs and MMSs are multipotent cells
that can give rise to multiple lineages, including bone, car-
tilage, fat and muscle [19-23]. MSCs may also be capable
of hepatic, renal, cardiac or neural differentiation, at least
in some limited contexts. In the bone marrow, MSCs and
MMSs function as a stem/progenitor cell reservoir for
renewal/replacement of numerous skeletal or associated
cell types and function as stromal cells supporting hema-
topoietic stem cell differentiation/development [20,23-25].
Owing to their capacity to differentiate along many differ-
ent axes, MSCs are an extremely attractive candidate for
use in regenerative medicine applications [20,24]. In this
context, it is critical to understand the mechanisms that
govern both normal MSC fitness and activity and potential
pathologies, especially cancers that may be linked with
MSC derangement. However, the factors that influence
the normal tissue-regenerative functions, while preventing
neoplastic transformation, of MSCs remain poorly
understood.
Our previous data suggested that patients with muta-
tions in Art or other NHEJ factors may also be at risk for
a host of nonlymphoid cancers, especially sarcomas, even
if the immunodeficiency can be corrected by bone mar-
row transplantation or gene therapy [8]. Here we have
further investigated the mechanistic role of ARTEMIS in
mesenchymal tumor suppression and in normal MSC
function and fitness. The importance of ARTEMIS in pri-
mary MSC derived from the bone marrow microenviron-
ment was tested in detail using knockout mice [26]. We
find that ARTEMIS is important for normal proliferative
control of MSCs, especially after exposure to various
cytostress stimuli. These findings add to the growing
evidence that, in addition to DNA repair functions,
ARTEMIS is a key factor in normal cell cycle response to
cellular stressors, such as DNA damage [11-14]. In this
context, we propose that Art-deficient MSCs acquire a
preneoplastic state in which normal proliferative control
is altered. The relevance to sarcomagenesis is discussed.
Results and Discussion
The NHEJ factor ARTEMIS suppresses sarcomagenesis
In the context of a lymphoma study, we previously
observed that deficiency for ARTEMIS in mice can be
associated with increased incidence of certain nonlym-
phoid tumors, including sarcomas. Because Trp53Δ/+ mice
are predisposed to broad-spectrum tumorigenesis, includ-
ing various sarcomas, we reasoned that effects of Art defi-
ciency would be readily detectable on the tumor-sensitized
Trp53-heterozygous background [27-29]. To investigate
the broad, tumor-suppressive functions of ARTEMIS, we
generated, in total, 750 Art-knockout (ArtΔ/Δ) mice that
were heterozygous for the p53 tumor suppressor gene
(Trp53). Of the 750 ArtΔ/Δ Trp53Δ/+ mice, 46 (6.1%) devel-
oped tumors of any kind. This is similar to, but slightly
lower than, the overall tumor incidence (17%) previously
reported for ArtΔ/Δ Trp53Δ/+ mice [30]. Of the 46 mice
developing tumors in our cohort, 14 (30.4%) developed
sarcomas of various subtypes. This is roughly the same as
the overall sarcoma incidence previously described for
Trp53Δ/+ [27,29]. Whereas the fraction of mice ultimately
developing sarcomas was similar in our ArtΔ/Δ Trp53Δ/+
and Trp53Δ/+ control mice, a higher fraction of ArtΔ/Δ
Trp53Δ/+ animals developed sarcomas over the initial 60-
week observation period (Figure 1a). This suggests that
Art deficiency may accelerate tumorigenesis in Trp53 het-
erozygote animals. Histopathological analysis after hema-
toxylin and eosin (H&E) staining revealed a range of
sarcoma subtypes occurring in ArtΔ/Δ Trp53Δ/+, including
chondrosarcoma, osteosarcoma and rhabdomyosarcoma
(Figure 1b). Notably, anaplastic sarcomas with poor,
ambiguous or heterogeneous differentiation were also con-
sistently observed (Figure 1b). Taken together, these data
imply a role for ARTEMIS in suppressing a range of
tumors, including several sarcoma subtypes in a tumor-
sensitized Trp53Δ/+ context.
Although we could only obtain metaphase chromo-
some spreads from two Art-deficient sarcomas, spectral
karyotype analysis of this sarcoma subset revealed aneu-
ploidy and hyperdiploidy, without grossly detectable
chromosomal translocations (Figure 1c; Additional file
1). While we cannot rule out chromosomal instability in
some Art-deficient sarcomas, the spectral karyotypes we
did analyze were reminiscent of human sarcoma karyo-
types, which commonly show aneuploidization without
consistent or clonal translocations [31-41]. These data
suggest that Art may suppress sarcomagenesis by
mechanisms that are at least partly independent of
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Figure 1 Art deficiency accelerates mesenchymal tumor development. (a) Tumor-free survival analyses of ArtΔ/Δ Trp53Δ/+ mice (red circles)
versus Trp53Δ/+ mice (blue, diamond). Plotted is the surviving fraction of those mice that developed tumors as a function of time (weeks).
Significance was determined by t-testing. (b) Hematoxylin and eosin (H&E) staining of an anaplastic sarcoma (left) and a chondrosarcoma
(center) found in ArtΔ/Δ/Trp53Δ/+ mice, shown at ×10 and ×40 magnification. Normal bone marrow from an Art mouse (right) is shown for
comparison. Boxed areas in ×10 magnification demarcate regions shown in ×40 magnification. Lines represent scale bars (200 μm in ×10
magnification; 50 μm in ×40 magnification). (c) Spectral karyotype (SKY) analysis of ArtΔ/Δ Trp53+/Δ osteosarcoma. Shown are the 4’,6’-diamidino-2-
phenylindole (DAPI) stained metaphase (inverted image, top left) with superimposed chromosome contours (blue), spectral image of SKY
painted metaphase spread (top, middle), and computer classified image (top, right), as well as the karyotype table showing approximate
hyperdiploidy (bottom).
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chromosomal stability control. In this context, the
observed aneuploidization may be indicative of a defect
in normal proliferation or growth control in the pre-
transformed or early transformed sarcoma cells of
origin.
Art is required for genome stability in primary MSCs
The occurrence of poorly differentiated sarcomas in
ArtΔ/Δ Trp53Δ/+ mice, as well as the range of differen-
tiated cell types identified, suggested origination of these
diverse tumors from a common precursor cell type. We
therefore focused on the role of ARTEMIS in multipo-
tent primary MSCs as candidate sarcoma cells of origin.
We first evaluated whether Art is expressed in normal
MSCs by a reverse transcriptase polymerase chain reac-
tion (RT-PCR) assay, originally used to analyze Art-
knockout (ArtΔ/Δ) embryonic stem cells [42]. Total RNA
was isolated from either wild-type (WT) or ArtΔ/Δ
MSCs, isolated by standard methods from correspond-
ing mice, and Art transcript was measured by RT-PCR
[19,42,43]. This verified that Art is transcriptionally
expressed in WT MSCs and confirmed ablation of Art
in mutant MSCs (Additional file 2).
We next assessed whether Art acts to prevent sponta-
neous chromosomal instability in MSCs. Untreated WT
or ArtΔ/Δ primary MSCs were analyzed by conventional
or spectral karyotyping (SKY). This revealed approxi-
mately the same rate (20%) of spontaneously occurring
aneuploidy in ArtΔ/Δ and WT MSCs (Figures 2a-c).
More detailed analysis of ArtΔ/Δ versus WT MSC meta-
phase spreads revealed similar overall range, distribution
and median in number of chromosomes per cell
(Figures 2b and 2c). However, ArtΔ/Δ MSCs also exhib-
ited a higher frequency of spontaneous chromosomal
structural lesions, that is, breaks, fragments, or translo-
cations, than their WT counterparts (17% versus 7%,
respectively) (Figures 2a and 2b). Collectively, these data
suggest that Art is critical to maintain overall genome
stability in primary MSCs, with key roles in preventing
chromosome fragmentation and aneuploidy. However,
these functions may be unrelated, or indirectly related,
to sarcoma suppression functions, as we find evidence
for sarcomagenesis without translocations.
Art is dispensable for MSC differentiation
We next tested whether Art deficiency affected MSC dif-
ferentiation competency. Normal MSCs can differentiate
into multiple cell types, including lipid-producing adipo-
cytes and calcium-depositing osteocytes [21-23]. For
these analyses, WT and ArtΔ/Δ MSCs were therefore cul-
tured under adipogenic or osteogenic, as well as nondif-
ferentiating (control), conditions (Figure 3) [19]. Cellular
response to differentiation medium was first tested by
evaluating changes in gross cell morphology via light
microscopy (Figure 3a). Responses to adipogenic medium
were apparent as early as 3 days after induction for both
WT and ArtΔ/Δ cultures, with cells evincing a rounded
morphology and accumulating characteristic lipid dro-
plets. After 7 days of adipogenesis, a substantial fraction
of both WT and ArtΔ/Δ cultures contained large lipid
vacuoles (Figure 3a). To confirm adipogenic differentia-
tion, WT or ArtΔ/Δ MSC cultures were fixed and stained
with the lipid binding fluorescent dye LipidTOX (Invitro-
gen, Carlsbad, CA, USA) (Figure 3a). WT and ArtΔ/Δ
MSC cultures each contained a high percentage of fluor-
escently labeled cells that were qualitatively indistin-
guishable from one another (Figure 3a). Similarly, ArtΔ/Δ
MSCs cultured under osteogenic conditions exhibited
morphological changes and calcium deposition compar-
able to WT MSCs, indicating essentially normal osteoid
differentiation potential (Figure 3b). As controls for dif-
ferentiation specificity, ArtΔ/Δ and WT control MSC cul-
tures were stained for off-target differentiation
(Additional file 3). Neither ArtΔ/Δ nor control cultures
showed evidence of inappropriate differentiation.
Together, these data demonstrate that ArtΔ/Δ MSC retain
grossly normal differentiation potential. To functionally
evaluate primary MSC recovery from bone marrow pre-
parations and to quantify differentiation competency,
ArtΔ/Δ versus WT MSC, LipidTOX-positive cells were
measured as a function of the total cell count at 0, 7 or
14 days after transfer to adipogenic, or nondifferentiating,
culture conditions (Figure 3c). Neither ArtΔ/Δ nor WT
MSC cultures showed significant increases in the Lipd-
TOX-positive fraction under nondifferentiating condi-
tions up to 14 days of culture (Figure 3c, gray lines).
Conversely, both ArtΔ/Δ and WT exhibited nearly identi-
cal increases in LipidTOX positivity at both 7 and 14
days of adipogenic culture (Figure 3c, black lines). These
results demonstrate that Art deficiency does not signifi-
cantly affect either the number or the differentiation
competency of primary MSCs relative to WT.
In addition to general differentiation competency,
MSCs were assessed for proliferative responses during
differentiation. WT or ArtΔ/Δ MSCs were transferred
from standard growth to either adipogenic, osteogenic
or control medium, cultured for up to 14 days and mea-
sured at various culture time points for mitotic index as
a marker of actively proliferating cells by immunostain-
ing for phosphorylated histone H3 (phospho-H3), a
mitosis-specific marker.
During culture in nondifferentiation, adipogenic or
osteogenic medium ArtΔ/Δ and WT MSC cultures
exhibited similar phospho-H3 cell counts throughout
the 14-day measurement time course (Figures 3d-g).
Together with the differentiation data above, these
results demonstrate that Art deficiency does not quanti-
tatively affect the number of bone marrow MSCs, as
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defined by functional differentiation and cell prolifera-
tion assays.
Art modulates the response to induced DNA damage in
MSCs
Because the NHEJ pathway is critical in other cell types
for resistance to DNA double-stranded break-inducing
agents such as ionizing radiation (IR), we asked whether
ArtΔ/Δ MSCs were radiosensitive relative to WT con-
trols. Initially, growth rates for WT versus ArtΔ/Δ MSCs
were compared in the absence of irradiation. Low-pas-
sage isolates of primary WT or ArtΔ/Δ MSCs or mouse
embryonic fibroblast (MEF) controls were seeded in
replicate cultures with fresh medium at the same density
(5 × 104 total cells), and expansion was assessed
by manual cell counting at 2-day intervals for 10 days
(Figure 4a). This analysis revealed no overt differences
between ArtΔ/Δ and WT MSCs or MEFs, although the
ArtΔ/Δ MEFs showed a slightly faster initial expansion
than their counterpart WT MEFs (Figure 4a). Overall,
this indicated that Art deficiency did not grossly com-
promise MSC growth under nonstress conditions.
Next, we evaluated ArtΔ/Δ versus WT MSCs for radio-
sensitivity by two different assays. First, we performed a
colony formation assay following irradiation of WT or
ArtΔ/Δ MSCs at doses ranging from 0 to 3.5 Gy. After
Figure 2 Art prevents chromosome instability in MSCs. (a) SKY analysis of wild type (WT) (top) or ArtΔ/Δ (bottom) mesenchymal stem cells
(MSCs). An example of a chromatid break, typifying damage in ArtΔ/Δ cells, is indicated by an arrow and shown magnified. (b) Summary of
spontaneous chromosomal abnormalities in WT versus ArtΔ/Δ. (c) Distribution of chromosome number in WT versus ArtΔ/Δ MSC karyotypes.
Shown is the percentage of metaphase spreads from each karyotype harboring the indicated number of chromosomes.
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Figure 3 Art-deficient MSCs differentiate normally. (a) ArtΔ/Δ and WT MSCs were grown in adipogenic culture medium for 7 days, fixed and
stained with the fluorescent lipid-binding dye LipidTOX (Invitrogen). Shown are bright field, fluorescent and merged images for each. (b) ArtΔ/Δ
and WT MSCs were grown in osteogenic culture medium for 14 days, fixed and stained with Alizarin red to detect mineralization indicative of
osteocytic development. (c) ArtΔ/Δ and WT MSCs were grown in adipogenic or unsupplemented culture medium for 14 days, fixed and stained
with LipidTOX and DAPI counterstain. The fraction of LipidTOX-positive cells was determined for each sample and culture condition at days 0, 7
and 14. Error bars indicate standard error. (d-f) Mitotic indices for undifferentiated, adipogenic or osteogenic cultures of ArtΔ/Δ and WT MSCs
were determined by immunostaining for M-phase marker phosphorylated histone H3 (phospho-H3). (d) Representative fluorescence micrographs
of phospho-H3-positive cells (green), DAPI DNA counterstain (blue), and merged are shown for ArtΔ/Δ and WT MSCs. Scale bars, 10 μm. Fractions
of positive phospho-H3 staining were determined at days 0, 3, 7 and 14 of (e) undifferentiated control, (f) adipogenic or (g) osteogenic culture
conditions. Error bars indicate standard error.
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irradiation, serial dilutions were plated and cultured
until colonies were visibly evident in unirradiated sam-
ples. Colony counts were determined after staining with
crystal violet, and all data were normalized to unirra-
diated colony counts. As controls, radiosensitivity was
also determined for ArtΔ/Δ or WT fibroblasts, with the
former previously shown to be hypersensitive to IR
exposure [26]. ArtΔ/Δ fibroblasts expectedly showed IR
hypersensitivity relative to WT fibroblasts, especially
at intermediate doses (Figure 4c). By contrast, ArtΔ/Δ
and WT MSCs were essentially indistinguishable
for radiosensitvity at all doses tested, but MSCs of both
Figure 4 Art is dispensable for MSC resistance to ionizing irradiation. (a) Three independent biological replicates of WT or ArtΔ/Δ MSCs or
control fibroblasts were plated at 5 × 104 cells per dish each and cultured for 10 days. Viable cell counts, measured by exclusion of the vital dye
trypan blue, were determined every 2 days. Error bars indicate standard error. (b) Clonogenicity assay for sensitivity to ionizing irradiation. A total
of 1 × 105 WT or ArtΔ/Δ MEFs or 5 × 105 WT or ArtΔ/Δ MSCs were irradiated at the indicated doses, plated to 100-mm dishes and cultured until
colonies were visibly evident for the unirradiated WT controls of each cell type. Cells on all plates were then fixed and stained with crystal violet
histological stain. (c) Quantification of clonogenicity (from (b)) following IR. Colonies were counted and normalized to the unirradiated control
for MEFs or MSCs, respectively. Error bars indicate standard error. (d) WT and ArtΔ/Δ MSCs or control fibroblasts were exposed to ionizing
radiation (IR) at indicated doses, plated at equivalent densities in triplicate and harvested for analysis after 7 days. Viable cell counts were
determined for single-cell suspensions by trypan blue exclusion. Relative resistance to IR is expressed as the viable cell count at each dose
normalized to the unirradiated control for each sample. Error bars denote standard error.
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genotypes were overall significantly more IR-sensitive
than WT fibroblasts (Figure 4c). As a second assay, we
measured the total number of viable cells in culture,
irrespective of colony-forming potential, after irradiation
at doses ranging from 0 to 5 Gy. Cell suspensions of
ArtΔ/Δ or WT MSCs or MEFs were irradiated, plated
and cultured for 7 days, and then scored for viable cells
by manual cytometry. Surviving cell counts were nor-
malized to unirradiated cultures (Figure 4d). As in the
colony formation assay, we observed the relative IR
hypersensitivity in ArtΔ/Δ MEFs, but not MSCs, relative
to the corresponding WT cells. Notably, by this assay,
both WT and ArtΔ/Δ MSCs were more sensitive than
their counterpart MEFs to IR at all doses.
Art modulates MSC proliferation following ionizing
irradiation
At sublethal doses, clastogens such as IR can also pro-
voke either temporary or permanent arrest of mitotic
activity in normal cells. To test whether Art modulates
MSC proliferative control following irradiation, ArtΔ/Δ
or WT control MSCs were g-irradiated and cultured as
described above, but mitotic activity was determined by
measuring the fraction of metaphase nuclei after 24
hours of recovery (Figures 5a and 5B). ArtΔ/Δ MSC cul-
tures showed slightly lower mitotic indices than WT
cultures at 0 and 0.5 Gy, but significantly higher mitotic
indices at 1 and 2 Gy (Figures 5a and 5b). Above 2 Gy,
mitotic activity in both genotypes was dramatically
reduced, and cellular viability of WT MSC was signifi-
cantly impaired (Figure 5b).
To measure the kinetics of mitotic response to
IR, WT or ArtΔ/Δ MSCs were subjected to 1 Gy of
g-irradiation, and the mitotic index was determined by
immunofluorescent detection of phosphorylated histone
H3 (pH3) at 0, 6, 12 or 24 hours after irradiation (Fig-
ures 5c-g). As controls, WT or ArtΔ/Δ MEFs were simi-
larly irradiated and analyzed, with the latter known to
be hypersensitive to IR exposure. WT MSCs showed an
initial increase in mitotic index following irradiation,
approximately doubling by 6 hours, then declining to
preirradiation levels by 12 hours (Figures 5d and 5e).
Relative to WT, ArtΔ/Δ MSCs showed a prolonged mito-
tic response to IR, with mitotic index increasing twofold
by 6 hours, reaching a peak level of 2.5-fold by 12 hours
and remaining elevated at 24 hours (Figures 5d and 5e).
By contrast, ArtΔ/Δ MEFs showed elevated mitotic index
in unirradiated cultures relative to WT MEFs, but did
not exhibit a sustained increase in mitotic index follow-
ing irradiation as in WT cells (Figures 5f and 5g).
Altogether, these results suggest that Art is dispensa-
ble for overall resistance to genotoxic stress in multipo-
tent adult MSCs, but that Art critically modulates MSC
cell cycle response following ionizing irradiation. The
underlying basis for the dichotomy between MSCs and
fibroblasts for IR resistance is not known, but a similar
phenomenon was previously observed in the context of
embryonic stem cells (ESCs) [26,41]. Art deficiency did
not hypersensitize ESCs to DNA damaging agents, but
WT and ArtΔ/Δ ESCs were generally more sensitive
than corresponding fibroblasts. It is possible that this
represents a difference in the importance of the NHEJ
pathway in stem/progenitor versus more differentiated
cell types.
Art-deficient MSCs are resistant to serum deprivation
stress
Previous studies have suggested that normal MSCs are
acutely sensitive to culture stress, especially by dimin-
ished serum concentration [44,45]. We therefore tested
whether lack of Art affected MSCs’ sensitivity to serum
deprivation. Initially, after transfer to serum-free med-
ium, ArtΔ/Δ MSCs appeared indistinguishable from WT,
for both cell density and morphology (Figure 6a). How-
ever, pronounced differences in cellular morphology and
density rapidly manifested between WT and ArtΔ/Δ
MSCs following serum withdrawal (Figures 6a and 6b;
Additional files 4, 5, 6, 7). ArtΔ/Δ cells were remarkably
resistant to serum starvation as compared with WT
MSCs. After 6 days in serum-free medium, ArtΔ/Δ cul-
tures retained adherent, viable cells with largely normal
morphology (Figure 6a; Additional file 5). By contrast,
WT MSC cultures exhibited a decrease in cell density
accompanied by marked changes in cell morphology,
including rounding and detachment from the culture
substrate (Figure 6a; Additional file 7). After 7 days of
serum deprivation, ArtΔ/Δ or WT MSCs were harvested
and the remaining viable cells were counted (Figures 6c
and 6d). This confirmed that Art-mutant MSC cultures
were significantly more resistant to serum withdrawal
than WT MSC, with ArtΔ/Δ cultures exhibiting greater
than fourfold higher survival than WT cultures (Figures
6c and 6d).
Misregulation of stress response, proliferation and
differentiation pathways in ArtΔ/Δ MSCs
To begin identifying genetic pathways involved in the
remarkable resistance of ArtΔ/Δ MSCs to serum withdra-
wal stress, we carried out a microarray-based compara-
tive transcriptome analysis. Freshly isolated WT or ArtΔ/
Δ MSC cultures were grown in duplicate experiments
under either normal or serum withdrawal conditions
(identical to above), RNA was isolated from each cul-
ture, and samples were analyzed for differential gene
expression changes via hybridization to Affymetrix Gen-
eChip Mouse Genome 430 2.0 microarrays (Affymetrix,
Santa Clara, CA, USA). Gene expression differences
between serum-starved and normal cells were identified
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Figure 5 Art modulates cell cycle response following IR. (a) Representative micrographs of WT and ArtΔ/Δ MSC metaphase spreads. (b) The
mitotic indices of WT (filled bars) and ArtΔ/Δ (open bars) MSCs following exposure to IR at indicated doses were determined by quantification of
metaphase cells. Mitotic index is expressed as the percentage of mitotic figures per total nuclei. Significance was determined by t-testing (**P <
0.01; ***P < 0.005). (c-g) The mitotic indices of WT and ArtΔ/Δ MSCs or control fibroblast 6, 12 and 24 hours following 1 Gy ionizing irradiation
were determined by immunostaining for the mitotic marker pH3. (c) Shown are representative merged micrographs of pH3+ (green) and DAPI
DNA counterstained (blue) WT or ArtΔ/Δ MEFs and MSCs at each time point after IR. Scale bars, 10 μm. The fraction of phospho-H3-positive cells
for WT (filled bar) and ArtΔ/Δ (open bar) MSCs (d) or MEFs (f) were determined for each time point after IR. Data from (d and f) were also
normalized to the 0 Gy controls. Normalized data are shown for MSC (e) and MEF (g). Error bars indicate standard error.
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independently for WT and for ArtΔ/Δ MSC cultures and
expressed as a relative fold change (RFC) in the serum-
starved relative to normal conditions (Figure 7a). By this
approach, a total of 91 genes with a greater than three-
fold difference (either upregulated or downregulated)
were uniquely identified for WT MSCs, while only 34
genes showed greater than threefold differences specifi-
cally in ArtΔ/Δ MSC and 32 genes were common to
both WT and ArtΔ/Δ MSCs (Figures 7b and 7c). Of the
157 genes deregulated in either WT or ArtΔ/Δ MSC, the
majority (109 of 157 = 69%) showed a higher RFC in
WT cultures than in the corresponding ArtΔ/Δ cultures
(Figure 7b). Similarly, among the deregulated genes
common to both WT and ArtΔ/Δ cells, 19 (59%) of 32
exhibited a higher RFC in the WT than in the ArtΔ/Δ
samples (Figure 7c). These data suggest that ArtΔ/Δ cells
experience a muted overall response to serum withdra-
wal, manifested as a less dynamic change in gene
expression relative to WT. In this context, ArtΔ/Δ MSCs
are likely resistant to serum deprivation owing to an
overall attenuated biological response.
To identify genes that may specifically relate to this
muted stress response in MSCs, the difference in WT
versus ArtΔ/Δ RFCs (ΔRFC) were determined for each
Figure 6 Art-deficient MSCs are resistant to culture stress by serum withdrawal. (a) Light micrographs of ArtΔ/Δ or WT MSCs exposed to
serum-free (serum starvation) versus normal (10%) serum (control) culture conditions. Cell cultures were photographed after either 2 or 6 days of
serum withdrawal. (b) ArtΔ/Δ and WT MSCs after culture in normal conditions for 6 days. (c) Viability of WT (filled bars) versus ArtΔ/Δ (open bars)
MSCs after culture in normal (control) or serum withdrawal (serum starved) conditions for 7 days. Viable cell counts were determined as the
number of trypan blue-excluding cells normalized to the normal serum control. (d) Fold reduction in survival of WT (filled bars) or ArtΔ/Δ (open
bars) following 7 days of serum withdrawal. Significance in all assays was determined by t-testing (***P < 0.005).
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Figure 7 ArtΔ/Δ MSCs show an attenuated transcriptional response to serum withdrawal. (a) Schematic showing experimental design for
comparative gene expression analysis. RNA was isolated from duplicate cultures representing either WT (blue) or ArtΔ/Δ (red) MSCs cultured in
either normal (solid line with filled nuclei) or serum starvation (dashed line with open nuclei) media. All samples were analyzed by hybridization
to Affymetrix GeneChip Mouse 430 2.0 microarrays. Relative fold change (RFC) in transcription levels was determined for serum-starved cells
versus corresponding controls in WT and in ArtΔ/Δ samples. Using a threshold of threefold or greater RFC, WT and ArtΔ/Δ data were comparatively
analyzed and results were categorized as unique to WT cells (blue), unique to ArtΔ/Δ cells (red) or common to both (overlap). In total, 157 genes
were identified with a threefold or greater RFC in WT or ArtΔ/Δ or both. Number of genes identified in each category is indicated on the Venn
diagram. (b) RFC data for each of the 157 genes in (a). Shown are RFC data for each gene in WT cells (blue bars) and in ArtΔ/Δ cells (red bars).
Negative RFC values indicate lower expression in serum-starved cells relative to control; positive RFC values indicate elevated expression in
serum-starved cells relative to controls. (c) RFC for genes common to both WT and ArtΔ/Δ cells from (a). Plotted are RFC for WT (blue) and ArtΔ/Δ
(red) cells as in (b).
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gene, and all genes were then ranked. Using a lenient
twofold or greater ΔRFC cutoff, this analysis defined
two subsets of differentially regulated genes: those with
higher overall expression in WT than in ArtΔ/Δ-positive
(ΔRFC in Figure 8a) and those with lower overall
expression in WT than in ArtΔ/Δ (negative ΔRFC in
Figure 8a). Analysis of gene ontology (GO) annotations
revealed that these differentially perturbed subsets were
enriched for genes involved in (1) bone morphogenesic
protein (BMP) or Wingless and Int (WNT) signaling
pathways (indicated by red/green bars in Figure 8b) and
(2) growth factor response and signaling (indicated by
blue/orange bars in Figure 8b). These results are inter-
esting, as numerous studies have previously implicated
BMP signaling and WNT signaling in multiple types of
sarcomagenesis and sarcoma metastasis [46-66,73].
Moreover, alteration in normal growth factor respon-
siveness is a general hallmark of tumorigenesis in
numerous cell types. Altogether, these data reinforce the
interpretation that ArtΔ/Δ MSCs adopt a stress-resistant,
aberrantly proliferative behavior likely related to misre-
gulation of normal MSC growth and differentiation
pathways.
GO analysis also showed that the list of 157 deregu-
lated genes was enriched for genes annotated to the bio-
logical processes of stress response, cell proliferation
and cell differentiation. Collectively, these data suggest a
model in which cell stress (here via serum withdrawal)
normally prompts deregulation of cell proliferation and
BMP/WNT-dependent MSC differentiation pathways.
We speculate that simultaneous proliferative and anti-
proliferative signals, evoked by cell stress, culminate in
cell death, and that Art functions in part to modulate
the response to these signals.
Conclusions
Genomic instability is recognized as a major feature of
many, if not all, cancers. However, the mechanisms that
maintain normal genomic integrity and their roles in
preventing neoplastic transformation are not completely
understood. Here we have investigated the role of the
nonhomologous end joining pathway of DNA double-
stranded break repair in multipotent MSCs/progenitor
cells in relation to sarcomagenesis. The cancer stem cell
hypothesis posits that stem or stemlike cells are respon-
sible for cancer initiation, metastasis, therapy resistance
and relapse after remission. In this context, there is
growing evidence to suggest a role for MSCs or MMSs
in the development of many sarcomas. Previous studies
have shown that ArtΔ/Δ Trp53Δ/+ mice are susceptible to
tumorigenesis with shorter latency and an altered spec-
trum relative to Trp53Δ/+ mice. We find overall tumor
incidence in ArtΔ/Δ Trp53Δ/+ mice similar to prior stu-
dies, but observed a higher incidence of sarcomas than
seen in at least one prior study [30]. The basis for this
difference in tumor spectrum is not known but may be
related to differences in mouse strain background or the
prolonged observation period in our study [30]. Impor-
tantly, we find evidence for sarcomagenesis without clo-
nal chromosomal translocation in ArtΔ/Δ cells [67]. This
is striking, given the well-documented DNA double-
stranded break repair and genome stability functions of
Art. Rather, we propose that defects in proliferation
control following cellular stress can render Art-defective
(and perhaps other NHEJ-deficient) MSCs or MMSs
preneoplastic. In this context, checkpoint regulatory
activities of ARTEMIS may be more important than the
DSB repair function with regard to sarcoma suppression
[12-14]. Taken together, our results suggest that in a
sensitized genetic context or with the right series of sub-
sequent genetic hits, potentially preneoplastic MSCs
might give rise to sarcomas with differentiation into var-
ious lineages [67-69]. It will be interesting to determine,
via structure-function studies, which molecular activities
of ARTEMIS may differentially contribute to its lym-
phoma versus sarcoma suppressive functions. It will also
be important to assess whether ARTEMIS is relevant to
tumor suppression in other tissues, and if so, which
functions are important.
In primary multipotent mesenchymal stem or stromal
cells (MSC/MMS) we have shown roles for Art in both
genome stability and cell proliferation control. Together
these results suggest that Art may function in general
DNA double-stranded break repair, as it does in other
cell types. But in MSCs, Art may also integrate cell cycle
responses to cellular stress. Whereas Art deficiency did
not lead to overt defects in either the number or differ-
entiation function of primary bone marrow-derived
MSCs, lack of Art did result in aberrant proliferative
responses to cellular stress conditions such as ionizing
radiation or serum deprivation, conditions that are nor-
mally cytostatic to WT MSCs and MMSs. Our data are
consistent with a growing body of evidence that ARTE-
MIS regulates checkpoint responses, perhaps in multiple
phases of the cell cycle [11-14]. ARTEMIS is known to
be a phosphorylation target of ATR and ATM kinases
and was found to be important for proper recovery
from both S- and G2/M checkpoints [12,14]. Our data
build on the previous studies of Art-dependent cell cycle
checkpoint control in various cell types [12-14]. We
now report a role for Art in cell cycle response to IR in
primary MSCs. Our control data in primary fibroblasts
differ somewhat from previous studies. Geng et al. [13]
showed that wild-type human embryonic kidney (HEK)-
293 cell line cultures experienced a reduced phospho-
H3 staining by 6 hours after 3 Gy ionizing irradiation
and began showing a rebound in phospho-H3 (and thus
mitotic) cells by 12 hours after irradiation [13]. These
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Figure 8 Deregulation of stress-response, proliferation and differentiation pathways in serum-starved ArtΔ/Δ MSCs. (a) Difference in RFC
(ΔRFC) between WT and ArtΔ/Δ cells (defined as [WT RFC] - [ArtΔ/Δ RFC]) was determined for the 157 genes identified in Figure 7a. Plotted are
data for all genes showing ΔRFC = 2 or greater. Positive ΔRFC values indicate a higher RFC in WT than in ArtΔ/Δ samples; conversely, negative
ΔRFC values denote lower RFC in WT than in ArtΔ/Δ samples. Individual gene names are indicated. (b) RFC for genes in (a) are indicated, with WT
(dark fill) and ArtΔ/Δ (light fill) data overlaid. Genes with gene ontology (GO) annotations in BMP/WNT signaling, or in other growth factor
signaling, are indicated by red/green (WT/ArtΔ/Δ) or blue/orange (WT/ArtΔ/Δ) shading, respectively. (c-e) RFC data for genes with GO annotations
for stress response (c), cell proliferation (d), or cell differentiation (e) are shown. RFC for each gene in WT (gray bars) and ArtΔ/Δ (open bars)
samples are overlaid. Individual gene names are indicated. Genes with in BMP, WNT or growth factor signaling pathways are highlighted in red.
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findings likely reflect an initial G2/M arrest in response
to DNA damage, followed by recovery from arrest
beginning at or before 12 hours. We found that wild-
type primary MEFs experience a modest increase in
phospho-H3 as early as 6 hours after 1 Gy of ionizing
irradiation, and a significant increase by 12 hours. Possi-
ble explanations for the differences between our control
MEF data and prior accounts may be differences in cell
cycle responses in MEF versus HEK-293 cells, or could
reflect kinetic differences that result from different IR
doses than those described here [13]. In either case, our
overall results are consistent with previous studies,
showing an important role for Art in modulating cell
cycle checkpoint responses to IR. Moreover, our data
may suggest a slightly different checkpoint function for
Art in MSCs, where it appears to enforce, rather than
overcome, the G2/M arrest, such that Art-defective
MSCs remain inappropriately proliferative after IR expo-
sure. Overall, the data presented here indicate a key cell
cycle regulatory function for Art that may also be cell-
context dependent [11-14,70].
In this latter context, we find misregulation of critical
growth regulatory pathways in serum-starved ArtΔ/Δ
MSCs. It is not currently known whether the genes we
have identified as differentially regulated in serum-
starved WT versus ArtΔ/Δ MSCs directly contribute to
the differences in stress sensitivity or alternatively repre-
sent biomarkers of the overall differential stress
response. However, it is possible that the pathways iden-
tified by our differential gene expression analysis influ-
ence the exact checkpoint functions of ARTEMIS,
perhaps in a cell type-dependent fashion, and may thus
account for the phenotypic differences we observe in
ArtΔ/Δ MSCs versus other cell types [12-14]. There is an
accumulating literature implicating differentiation and
growth factor pathways as critical in normal MSC func-
tion and homeostasis. Here we have identified BMP,
WNT, and growth factor signaling pathways as differen-
tially affected in serum-starved WT versus ArtΔ/Δ MSCs.
In this context, our identification of altered BMP4
expression is intriguing in light of a recent report show-
ing that BMP2 and BMP4 can induce cytoskeletal
changes that modulate cellular differentiation via altera-
tions of cell morphology [71]. Another recent report has
suggested that Igfbp5, which we have also identified in
this study, may be a key modulator of senescence in
some cellular contexts [72]. While we cannot presently
rule out other models, our findings may indicate that
stress-responsive changes in MSC gene expression are
linked to cell cycle control, perhaps via ARTEMIS.
Given the excitement that surrounds mesenchymal stem
cells and their potential in tissue bioengineering applica-
tions, it will be critical to understand the pathways that
are important for their normal functioning and for
preventing their neoplastic transformation. The findings
presented here imply that Art encodes a critical modu-
lator of MSC cellular stress and that the cell cycle
modulatory function of Art represents a key deter-
minant of tumorigenesis arising within tissues
engineered from MSCs.
Methods
Mice
ArtΔ/Δ and Trp53Δ/+ mice were derived and maintained
as previously described [8,26,29]. All animals were main-
tained in a barrier facility in accordance with Institu-
tional Animal Care and Use Committee-approved
protocols.
Multipotent stromal cell isolation and culture conditions
Total bone marrow was isolated from pools of three or
four wild-type C57B6/J or Art-null mice between 6 and
10 weeks of age. Independent biological replicates were
prepared from pools of independent mice from the
appropriate genotypes. Total bone marrow from each
pool was plated onto 1- to 150-mm tissue culture plates
in 25-mL volume growth medium (a-MEM containing
10% fetal bovine serum (FBS), penicillin/streptomycin,
and L-glutamate). When adherent cells became ~80%
confluent (approximately day 4-6 of culture), nonadher-
ent cells were washed away and cells were passaged
onto 3- to 150-mm culture dishes and then immediately
used to initiate experiments or were cryopreserved. For
all experiments, only low-passage MSC preparations
were used.
Cytogenetic analysis
To prepare metaphase chromosome spreads, 40 ng/mL
colcemid (KaryoMax; Invitrogen, Carlsbad, CA, USA)
was added to subconfluent culturing cells to induce
metaphase arrest. Cells were then transferred to hypo-
tonic KCl solution (75 mM) for 15 min at 37°C and
fixed by two changes of cold 3:1 methanol-acetic acid.
Metaphase chromosome preparations were dropped
onto slides and further processed for spectral karyotyp-
ing (SKY) according to the manufacturer’s protocols
(Applied Spectral Imaging, Corona, CA, USA). SKY ima-
ging was performed using an ASI complete cytogenetics
station (Applied Spectral Imaging) and analyzed with
dedicated analysis software (Applied Spectral Imaging).
Differentiation assays
For osteocyte and adipocyte differentiation, MSCs were
plated at 1 × 105 cells/35-mm well in triplicate. Twenty-
four hours after plating, cultures were changed to either
osteocyte-specific differentiation medium containing
10 nM dexamethasone (Sigma, St. Louis, MO, USA),
20 mM b-glycerol phosphate (Sigma), and 50 μM
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L-ascorbic acid (Sigma) or to adipocyte-specific differen-
tiation medium containing 0.5 μM dexamethasone
(Sigma), 0.5 μM isobutylmethylxanthine (Sigma), and 50
μM indomethacin (Sigma). Cells were treated with cell-
specific differentiation medium for 7-14 days. On the
final day of treatment, cells were fixed in 3% formalde-
hyde/2% sucrose for 10 minutes at room temperature
and stained for osteocyte differentiation with alizarin
red, which binds to mineralized bone or for adipocyte
differentiation with LipidTOX™ (Invitrogen), which
binds to neutral lipids. Two wells of each treatment
were stained for the cell type generated by differentia-
tion medium, while the third well was stained for the
opposite treatment as a specificity control.
Cell irradiation
MSCs or control fibroblasts were irradiated with the
indicated doses of g-irradiation from a 137Cs source, pla-
ted in triplicate (0.5 × 105 cells/35-mm well for MSCs;
0.5 × 105 cells/60-mm plate for fibroblasts) and cultured
for 7 days. Cells were then trypsinized and scraped to
dissociate all adherent cells, stained with trypan blue,
and counted using a hemacytometer. For immunofluor-
escence following irradiation, MSCs were cultured on
gelatin-coated glass coverslips, irradiated at the indicated
dose (ranging from 0-5 Gy), allowed to recover in cul-
ture and then fixed and processed for immunofluores-
cent staining (below in Immunofluorescence methods.).
Clonogenic Assay
Primary MSCs or MEFs were g-irradiated at doses from
0 to 3.5 Gy with a 137Cs source. A total of 1 × 105
MEFs or 5 × 105 cells were plated onto 100-mm culture
dishes and cultured until colony formation was visibly
obvious for the unirradiated WT control cells. All cells
were then fixed in 3% formaldehyde/2% sucrose for 10
minutes at room temperature and permeabilized with
0.5% Triton-X 100 in 1× phosphate-buffered saline
(PBS) for 5 minutes at room temperature. Cells were
stained in 0.5% crystal violet for 10 minutes at room
temperature, and colonies were manually counted.
Images were recorded by digital plate scanning.
Immunofluorescence
MSCs were plated at 1 × 105 cells/35-mm well in six-well
plates containing gelatinized coverslips. Cells treated
with regular MSC medium were fixed in 3% formalde-
hyde/2% sucrose for 10 minutes at room temperature
when approximately 80% confluent. Cells treated with
osteocyte or adipocyte differentiation medium were fixed
in the same manner on days 3, 7 and 14 of treatment.
Fixed cells were permeabilized with 0.1% Triton X-100 in
1× phosphate-buffered saline for 15 minutes, blocked in
2% fetal bovine serum for 1 hour at room temperature,
and stained with primary antibody to either phospho-H3
(1:200; Upstate; Millipore, Billerica, MA, USA) or phos-
pho-H2AX (1:400; Bethyl, Montgomery, TX, USA) for 16
to 18 hours at 4°C. Cells were then incubated for 30 min-
utes at room temperature in FITC-labeled goat anti-rab-
bit IgG (Vector Laboratories, Burlingame, CA, USA) and
mounted with Vectashield mounting medium containing
4’,6’-diamidino-2-phenylindole counterstain (DAPI; Vec-
tor Laboratories, Burlingame, CA). Images were captured
by epifluorescence wide-field imaging on a Nikon 90i
upright microscope (Nikon, Melville, NY, USA). Images
were analyzed using IPLab software (BD Biosciences,
Rockville, MD, USA) with minimal image processing.
Serum starvation
MSCs were plated in triplicate at a density of 0.5 × 105
cells/35-mm well. After 24 hours, cells were rinsed with
PBS and transferred to standard medium with 10% FBS or
to medium without serum. Cells were trypsinized, stained
with trypan blue and counted on day 7 of treatment.
Gene Expression Analysis
For gene expression profiling, freshly isolated WT or
ArtD/D MSCs were cultured in duplicate experiments.
When cultures reached approximately 80% confluence
in 15-cm culture dishes, medium was replaced with
fresh basic MSC culture medium (see above in Multipo-
tent stromal cell isolation and culturing methods) either
with 10% FBS or lacking serum. Cells were incubated at
37°C in a humidified culture incubator with 5% CO2 for
24 hours. Cells were harvested by manual plate scraping,
washed once in cold PBS, and stored at -20°C in RNA-
Later (Ambion; Applied Biosciences, Austin, TX, USA)
prior to RNA extraction. Standard Affymetrix protocols
for Genechip Mouse 430 2.0 (Affymetrix, Santa Clara,
CA, USA) were followed to isolate RNA and generate
all microarray data.
Additional material
Additional file 1: Aneuploidy without translocations in Art-null
sarcomas. Spectral karyotype (SKY) analysis of Art-null sarcomas: (a)
AP812, osteosarcoma; and (b) APJ4631, rhabdomyosarcoma. Shown for
each is the 4’,6’-diamidino-2-phenylindole (DAPI)-stained metaphase
(inverted image, top left) with superimposed chromosome contours
(blue), spectral image of SKY painted metaphase spread (top, middle),
and computer classified image (top, right), as well as the karyotype table
showing aneuploidy (bottom).
Additional file 2: The Art/Dclre1c, encoding ARTEMIS, is transcribed
in mesenchymal stem cells (MSCs). (a) Schematic of reverse
transcriptase polymerase chain reaction (RT-PCR) strategy to detect Art
transcript in wild-type (WT) versus ArtΔ/Δ MSCs. PCR product detecting
exons 1-4 (Art ex1-4) is common to both the WT and ArtΔ/Δ alleles
(because the knockout allele eliminates exons 5-6. PCR product detecting
exons 1-5 (Art ex1-5) is only amplified from WT cells, but not ArtΔ/Δ cells.
(b) RT-PCR reactions detecting Art ex 1-4, Art ex 1-5, or glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) (control) transcripts as indicated.
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Shown are data for either WT or ArtΔ/Δ fibroblasts or MSCs (as indicated
beneath). These data confirm detection of Art ex 1-4 in both WT and
ArtΔ/Δ MSCs, but detection of Art 1-5 only in WT MSCs. This confirms
transcriptional expression of Art in MSCs and verifies the expected
knockout in MSCs from ArtΔ/Δ mice.
Additional file 3: Control for differentiation specificity of WT or
ArtΔ/Δ MSCs. (a) Fixed ArtΔ/Δ and Art MSCs treated with adipocyte- and
osteocyte-specific differentiation medium were stained with the
fluorescent lipid binding dye LipidTOX. Cells grown in osteocyte-specific
medium are not positive for LipidTOX staining, indicating the absence of
adipocytes in these culture conditions. (b) Fixed ArtΔ/Δ and Art MSCs
treated with adipocyte- and osteocyte-specific differentiation medium
were stained with the mineralized bone-specific stain alizarin red. Cells
treated with adipogenic medium do not stain with alizarin red,
indicating that mineralized bone is not present in adipogenic-treated
cells.
Additional file 4: Photomicrograph of WT MSC culture following 2
days of serum withdrawal.
Additional file 5: Photomicrograph of WT MSC culture following 6
days of serum withdrawal.
Additional file 6: Photomicrograph of Art-null MSC culture
following 2 days of serum withdrawal.
Additional file 7: Photomicrograph of Art-null MSC culture
following 6 days of serum withdrawal.
List of Abbreviations
DSB: DNA double-stranded break; ESC: embryonic stem cell; Gy: Gray (= 100
rad); IR: ionizing radiation; MSC: mesenchymal stem cell; NHEJ:
nonhomologous end joining; RFC: relative fold change; SKY: spectral
karyotyping; WT: wild type.
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